- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05580237
Pressure Gradient vs. Flow Relationships in Patients With Symptomatic Valvular Aortic Stenosis (PREFLOW)
January 2, 2024 updated by: Henrik Vase, Aarhus University Hospital Skejby
Pressure Gradient vs. Flow Relationships in Patients With Symptomatic Valvular Aortic Stenosis - a Comparison Between High- and Low Gradient Subtypes
The objective of the present study is to investigate to hemodynamic profile at rest and during peak exercise of patients with suspected severe aortic stenosis and to compare flow- and pressure changes between high gradient patients and low gradient patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
26
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, 8200
- Aarhus University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with suspected severe AS scheduled for evaluation for aortic valve intervention
Description
Inclusion Criteria:
- Patients with suspected severe AS scheduled for evaluation for aortic valve intervention:
- LVEF > 50 %
- AVA < 1.0 cm2
- Symptomatic - at least equivalent to NYHA functional class II
Exclusion Criteria:
- Congenital heart disease
- Severe coronary artery disease (main stem, proximal LAD or 3 vessel disease)
- Moderate or severe aortic valve regurgitation
- Moderate or severe mitral valve regurgitation or stenosis
- Moderate or severe pulmonary valve regurgitation or stenosis
- Moderate or severe tricuspid valve regurgitation or stenosis
- Severe pulmonary hypertension (tricuspid valve pressure gradient of 60 mmHg)
- Right ventricular dysfunction (TAPSE < 17 mm)
- Restrictive cardiomyopathy or cardiac amyloidosis
- Constrictive pericarditis
- Inability to perform supine bicycle exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Severe aortic valve stenosis
|
Pressure recordings across the aortic valve with simultaneous flow measurements by right heart catheterization, during rest and during supine exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure and flow relationships across the aortic valve during rest and during supine exercise
Time Frame: 2 hours
|
Pressure drop across the aortic valve measured invasively.
Flow across the valve estimated by right heart catheterization in the absence of aortic valve regurgitation.
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Henrik Vase, MD, PhD, Department of Cardiology, Aarhus University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2019
Primary Completion (Actual)
December 1, 2023
Study Completion (Actual)
December 1, 2023
Study Registration Dates
First Submitted
May 10, 2022
First Submitted That Met QC Criteria
October 12, 2022
First Posted (Actual)
October 14, 2022
Study Record Updates
Last Update Posted (Estimated)
January 3, 2024
Last Update Submitted That Met QC Criteria
January 2, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-10-72-71-19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Stenosis
-
Azienda Ospedaliera "Sant'Andrea"University of Bologna; Politecnico di Milano; Centro Cardiologico Monzino; I.R.C...RecruitingAortic Stenosis | Calcific Aortic Valve Disease | Chronic Coronary Syndrome | Calcific Aortic StenosisItaly
-
Chinese Academy of Medical Sciences, Fuwai HospitalEdwards (Shanghai) Lifesciences Medical Supplies Co., Ltd.Not yet recruiting
-
National Institute of Cardiology, Warsaw, PolandThe Institute of Bioorganic Chemistry, Polish Academy of SciencesRecruitingAortic Stenosis | Low-gradient Aortic StenosisPoland
-
MiRusRecruitingAortic Stenosis | Symptomatic Severe Native Aortic StenosisUnited States
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteNot yet recruitingCardiovascular Diseases | Severe Aortic Valve StenosisSpain
-
RenJi HospitalRecruitingSevere Aortic Valve StenosisChina
-
Shanghai MicroPort CardioFlow Medtech Co., Ltd.CompletedSevere Aortic Stenosis | Transcatheter Aortic Valve ReplacemenChina
-
Idoven 1903 S.L.Recruiting
-
University of Tennessee Graduate School of MedicineShockwave Medical, Inc.Recruiting
Clinical Trials on Simultaneous right and left heart catheterization
-
Mount Sinai Hospital, CanadaHeart and Stroke Foundation of CanadaRecruitingHeart FailureCanada
-
Shanghai 10th People's HospitalRecruitingAtrioventricular Block | Atrial Fibrillation, Persistent | Heart Failure With Reduced Ejection Fraction | Sick Sinus SyndromeChina
-
University Hospital, EssenTerminatedHeart Failure With Preserved Ejection FractionGermany
-
Chinese Pulmonary Vascular Disease Research GroupRecruitingPulmonary Arterial Hypertension | Pulmonary HypertensionChina
-
University of North Carolina, Chapel HillTerminatedPulmonary Hypertension | Right Heart Failure Due to Pulmonary HypertensionUnited States
-
Feldman Cardiology, PLLCNot yet recruiting
-
UOSD Emodinamica Diagnostica e InterventisticaRecruitingPulmonary HypertensionItaly
-
University Hospital, RouenTerminatedAortic Valve Stenosis | Pulmonary HypertensionFrance
-
Samsung Medical CenterCompletedHeart Failure With Preserved Ejection Fraction | Left Ventricular Diastolic DysfunctionKorea, Republic of
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung DiseaseUnited States